dc.contributor.author | Mejía Meneses, Astrid Johana | spa |
dc.contributor.author | Paláu Castaño, María Teresa | spa |
dc.contributor.author | Zúñiga Martí, Claudio Antonio | spa |
dc.date.accessioned | 2020-10-27T14:21:54Z | |
dc.date.available | 2020-10-27T14:21:54Z | |
dc.date.issued | 2004-12-04 | |
dc.identifier.issn | 2382-4603 | |
dc.identifier.issn | 0123-7047 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12749/10462 | |
dc.description.abstract | El parásito Trypanosoma rangeli, protozoo de la familia Trypanoso-matidae, se considera no patógeno para el hospedero vertebrado; sin embargo, en las poblaciones del insecto vector produce efectos patogénicos que desencadenan en la muerte de los triatomíneos infectados. Este hemofl agelado comparte con Trypanosoma cruzi, agente etiológico de la enfermedad de Chagas, características bio-lógicas e inmunoquímicas tales como la distribución geográfica, los reservorios, vectores, hospederos vertebrados y determinantes antigénicos. Por esta razón es una fuente de confusión en el diagnóstico de la enfermedad de Chagas y debe ser considerado como un parásito de importancia médica. A pesar de lo anteriormente mencionado, el conocimiento sobre T. rangeli es muy poco y fragmenta-do en sus aspectos bioquímicos, inmunológicos y moleculares. En este artículo se presenta una revisión de características biológicas de este parásito con el fi n de enfatizar y estimular la investigación dándole la importancia que se merece. [Mejía AJ, Paláu MT, Zúñiga CM. Trypanosoma rangeli: Lo que se conoce y el impacto de su presencia. | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | spa | spa |
dc.publisher | Universidad Autónoma de Bucaramanga UNAB | |
dc.relation | https://revistas.unab.edu.co/index.php/medunab/article/view/214/197 | |
dc.relation.uri | https://revistas.unab.edu.co/index.php/medunab/article/view/214 | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | |
dc.source | MedUNAB; Vol. 7 Núm. 21 (2004): TDAH, Tuberculosis, Trypanosoma Rangeli; 166-171 | |
dc.subject | Ciencias biomédicas | |
dc.subject | Ciencias de la vida | |
dc.subject | Innovaciones en salud | |
dc.subject | Investigaciones | |
dc.title | Trypanosoma rangeli: Lo que se conoce y el impacto de su presencia | spa |
dc.title.translated | Trypanosoma rangeli: What was known and the impact of its presence | eng |
dc.publisher.faculty | Facultad Ciencias de la Salud | spa |
dc.publisher.program | Pregrado Medicina | spa |
dc.type.driver | info:eu-repo/semantics/article | |
dc.type.local | Artículo | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | |
dc.subject.keywords | Health Sciences | eng |
dc.subject.keywords | Medicine | eng |
dc.subject.keywords | Medical Sciences | eng |
dc.subject.keywords | Biomedical Sciences | eng |
dc.subject.keywords | Life Sciences | eng |
dc.subject.keywords | Innovations in health | eng |
dc.subject.keywords | Research | eng |
dc.subject.keywords | Parasite-vector relationship | eng |
dc.subject.keywords | Parasite-host relationship | eng |
dc.subject.keywords | Pathogenicity | eng |
dc.identifier.instname | instname:Universidad Autónoma de Bucaramanga UNAB | spa |
dc.type.hasversion | Info:eu-repo/semantics/publishedVersion | |
dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.relation.references | World Health Organization. Control of tropical disease. Chagas ́ disease. A disease whose days are numbered. World Health Organization, Geneva, Swtizerland, 1996 | spa |
dc.relation.references | Machado PE, Eger-Mangrich IR, Koerich G, Grisard LB, Steindel M. Differential susceptibility of triatomines of the genus Rhod-nius to nius to niusTrypanosoma rangeli strains from different geographical Trypanosoma rangeli strains from different geographical Trypanosoma rangeliorigins. Int J Parasitol 2001; 31:632-4 | spa |
dc.relation.references | Saldaña A, Sousa E. Diferencias y similitudes antigénicas entre Trypanosoma rangeli y Trypanosoma rangeli y Trypanosoma rangeliTrypanosoma cruzi. Rev Asoc Guatemal Parasitl. Med Trop 1991; 6:68-9 | spa |
dc.relation.references | Saldaña A, Örn A, Henriksson J, Sousa O. Evaluación de cuatro métodos inmunobioquímicos/moleculares en la identifi cación de cepas de Trypanosoma cruzi y Trypanosoma cruzi y Trypanosoma cruziTrypanosoma rangeli. Rev Méd (Panamá) 1993; 18:41-52 | spa |
dc.relation.references | Zúñiga CA, Paláu MT, Penin P, Gamallo C, de Diego JA. Protec-tive effect of Trypanosoma rangeli: against infection with highly virulent strain of Trypanosoma cruzi. Trop Med Int Health 1997; 5:482-7 | spa |
dc.relation.references | Cárdenas ME, Marinkelle CJ. Reactividad cruzada entre Trypano-soma rangeli y Trypanosoma cruzi y su posible papel protector en una infección chagásica en ratones. MedUNAB 1998; 1:14-21 | spa |
dc.relation.references | Introini M, Basso B, Moretti E. Enfermedad de Chagas experimen-tal: I. Estudio de diferentes condiciones de inmunización sobre el curso de la infección. Bol Chil Parasitol 1998; 53:45-51 | spa |
dc.relation.references | Paláu MT, Mejía MT, mejía AJ, Vergara U, Zúñiga CA. Action of Trypanosoma rangeli in infections with virulent Trypanosoma rangeli in infections with virulent Trypanosoma rangeliTrypanosoma cruzi populations. Mem Instit Oswaldo Cruz 2003; 98:543-8.cruzi populations. Mem Instit Oswaldo Cruz 2003; 98:543-8 | spa |
dc.relation.references | Hecker H, Schwarzenbach M, Rudin W. Development and interac-tions of Trypanosoma rangeli in and with reduviid bug Rhodnius Trypanosoma rangeli in and with reduviid bug Rhodnius Trypanosoma rangeliprolixus. Parasitol Res 1990; 76:311-8 | spa |
dc.relation.references | Gomes SAO, Feder D, Thomas NES, García ES, Azambuja P. Rhodnius prolixus infected with Rhodnius prolixus infected with Rhodnius prolixusTrypanosoma rangeli: In vivo and in vitro experiments. J Invert Pathol 1999; 73:289-93 | spa |
dc.relation.references | Basseri HR, Tew IF, Ratcliffe NA. Identifi cation and distribution of carbohydrate moieties on the salivary glands of Rhodnius prolixus and their possible involvement in attachment/invasion prolixus and their possible involvement in attachment/invasion prolixusby Trypanosoma rangeli. Exp Parasitol 2002; 100:226-34 | spa |
dc.relation.references | Cuba-Cuba CA. Revisión de los aspectos biológicos y diagnós-ticos del Trypanosoma (Herpetosoma) rangeli.Rev Soc Med Trop (Brasil) 1998; 31:207-220 | spa |
dc.subject.lemb | Ciencias médicas | spa |
dc.subject.lemb | Ciencias de la salud | spa |
dc.subject.lemb | Medicina | spa |
dc.identifier.repourl | repourl:https://repository.unab.edu.co | |
dc.description.abstractenglish | The parasite Trypanosoma rangeli, a protozoan of the family Trypanoso-matidae, is considered non-pathogenic for the vertebrate host; However, in the insect vector populations it produces pathogenic effects that lead to the death of infected triatomines. This agelated hemophilia shares with Trypanosoma cruzi, the etiological agent of Chagas disease, biological and immunochemical characteristics such as geographical distribution, reservoirs, vectors, vertebrate hosts and antigenic determinants. For this reason it is a source of confusion in the diagnosis of Chagas disease and should be considered a parasite of medical importance. Despite the aforementioned, knowledge about T. rangeli is very little and fragmented in its biochemical, immunological and molecular aspects. This article presents a review of the biological characteristics of this parasite in order to emphasize and stimulate research, giving it the importance it deserves. [Mejía AJ, Paláu MT, Zúñiga CM. Trypanosoma rangeli: What is known and the impact of its presence. | eng |
dc.subject.proposal | Trypanosoma rangeli | spa |
dc.subject.proposal | Trypanosoma cruzi | spa |
dc.subject.proposal | Relación parásito-vector | spa |
dc.subject.proposal | Relación parásito-hospedero | spa |
dc.subject.proposal | Patogenicidad | spa |
dc.type.redcol | http://purl.org/redcol/resource_type/ART | |
dc.rights.creativecommons | Atribución-NoComercial-SinDerivadas 2.5 Colombia | * |